Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.
[This corrects the article DOI: 10.1371/journal.ppat.1005537.].
Saved in:
| Main Authors: | Rosemarie D Mason, Hugh C Welles, Cameron Adams, Bimal K Chakrabarti, Jason Gorman, Tongqing Zhou, Richard Nguyen, Sijy O'Dell, Sabrina Lusvarghi, Carole A Bewley, Hui Li, George M Shaw, Zizhang Sheng, Lawrence Shapiro, Richard Wyatt, Peter D Kwong, John R Mascola, Mario Roederer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-05-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1005674&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
by: Omotayo Farinre, et al.
Published: (2025-01-01) -
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.
by: Hugh C Welles, et al.
Published: (2022-06-01) -
Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
by: Nami Iwamoto, et al.
Published: (2021-01-01) -
Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
by: Michael W Grunst, et al.
Published: (2023-05-01) -
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
by: Michelle C Crank, et al.
Published: (2016-01-01)